Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-17

Clinical Trial Update: Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T [Phase 2]

View source ↗

Summary

Phase 2 efficacy trial evaluating implantation of mouse renal adenocarcinoma macrobeads in men with castration-resistant prostate cancer that progressed despite…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mouse Renal Adenocarcinoma Macrobeads Implantation
  • sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: The Rogosin Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-10-17